Infliximab: profile and news

Analysis: Remicade works for psorasis  07 Mar 2006
SAN FRANCISCO, March 6 (UPI) -- Remicade (infliximab) -- a drug already approved by the Food and Drug Administration for the treatment of rheumatoid arthritis ... - United Press International

Infliximab for Crohn’s Disease Not Associated with Increased ...  Feb 8, 2006
According to a recent article published in the journal Gut, the agent infliximab that is commonly used for the treatment of Crohn’s disease does not appear ... - Cancer Consultants (press release),

REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement ...  Mar 3, 2006
SAN FRANCISCO, March 3 /PRNewswire/ -- Phase 3 data show treatment with REMICADE(R) (infliximab) resulted in rapid, significant improvement and long- term ... - PR Newswire (press release),

REMICADE(R) Phase 3 Data Show Rapid and Significant Improvement ...  Mar 3, 2006
Level, Sustained Response with Maintenance Therapy SAN FRANCISCO, March 3 /PRNewswire/ -- Phase 3 data show treatment with REMICADE(R) (infliximab) resulted in ... - PR Newswire (press release),

FDA Approves Rituxan for Refractory Rheumatoid Arthritis  Mar 1, 2006
...in combination with methotrexate in patients with moderate-to-severe RA that has been refractory to treatment with Enbrel (etanercept) or Remicade (infliximab ... - MedPage Today,

Genentech/Biogen Idec: Rituxan further expands its options  Mar 2, 2006
...treatments (DMARDs), followed by the more expensive biologics such as Amgen's Enbrel (etanercept) or Johnson & Johnson's Remicade (infliximab), which are both ... - Pharmaceutical Business Review

FDA clears Rituxan for rheumatoid arthritis  Mar 1, 2006
...in patients who have not responded to biologic therapy based on tumour necrosis factor blockers, namely Centocor's Remicade (infliximab), Amgen/Wyeth's Enbrel ... - Pharma Times (subscription),

Genentech, Biogen Idec Gain Approval Of Rituxan In RA  Mar 1, 2006
TNF antagonist therapies such as Enbrel (etanercept, from Amgen Inc.), Humira (adalimumab, from Abbott Laboratories) and Remicade (infliximab, from Johnson & ... - BioWorld Online (subscription),

Three-year studies on a novel therapy for rheumatoid arthritis ...  Feb 22, 2006
England Journal of Medicine is that abatacept works very well even in those patients who have failed on other biologic agents, such as etanercept and infliximab ... - Canada NewsWire (press release),

BAMBOO SPINE, A SPECIAL KIND OF ARTHRITIS  Feb 25, 2006
Pamidronate, a medicine used for osteoporosis, has also been found effective for AS; so have two newer drugs, infliximab and etanercept. DEAR DR. ... - Charlotte Sun-Herald,

Rheumatic Diseases Remain a Significant Cause of Chronic Illness ...  Feb 22, 2006
Juvenile arthritis is the next indication due for approval for blockbuster biologic therapies Remicade (infliximab) and Humira (adalimumab). ... - Business Wire (press release),

Better Fix For Rheumatoid Arthritis  Feb 16, 2006
...which contribute to inflammation. Examples are etanercept, infliximab, adalimumab and anakinra. • Protein-A Immunoadsorption Therapy ... - WFtv.com,

American Journal of Clinical Nutrition, Vol. 83, No. 2, 475S-483S ...  Feb 17, 2006
...shown by the fact that recombinant drugs that block the activity of either TNF- [etanercept (Enbrel; Amgen, Thousand Oaks, CA); infliximab (Remicade; Centocor ... - Am J Clin Nutr (subscription),

Inflammatory Diseases - Both Chronic Diseases, Such as Rheumatoid ...  Feb 1, 2006
CD). Nearly all sales were generated by the three available anti-TNF-a agents: etanercept, infliximab, and adalimumab. -- Twenty ... - Genetic Engineering News,

Novel drug treatments help against gout and colitis  Jan 31, 2006
Infliximab, sold under the brand name Remicade for arthritis and Crohn's disease, was shown to sharply reduce bloody diarrhea, abdominal cramps and other ... - Montreal Gazette,